Summary:
This is a study which is 52 weeks in duration, designed to confirm the safety and efficacy of XXX for moderate-to-severe atopic dermatitis.
Qualified Participants Must:
• Study participants must be 12 years or older
•
Have had Eczema/Atopic Dermatitis for over a year
•
Have Eczema/Atopic Dermatitis on at least 10% of the body surface
Qualified Participants May Receive:
Compensation for time and travel,
No-cost study related care,
and no-cost study treatment